Momentus raises $7 million through warrant exercise agreement
Get Alerts MNTS Hot Sheet
Join SI Premium – FREE
Momentus Inc. (NASDAQ: MNTS) entered into a warrant inducement agreement with an institutional investor for the immediate exercise of warrants to purchase 4,979,738 shares of common stock, generating approximately $7.0 million in gross proceeds.
The transaction involves the exercise of March 2025 warrants for 2,142,858 shares at a reduced price of $1.43 per share and July 2025 warrants for 2,836,880 shares at $1.41 per share. The company plans to use net proceeds for working capital and general corporate purposes.
In exchange for the immediate warrant exercise, the investor will receive new October 2025 Class A warrants to purchase up to 7,469,607 shares at an exercise price of $1.43. These new warrants will become exercisable upon stockholder approval and will expire five years from the approval date.
The closing is expected to occur around October 15, 2025, subject to customary closing conditions. A.G.P./Alliance Global Partners served as the exclusive financial advisor for the transaction.
The new warrants were offered through a private placement to accredited investors under an exemption from Securities Act registration requirements. Momentus has agreed to file a registration statement with the SEC covering the resale of common stock issuable upon exercise of the new warrants.
Momentus operates as a commercial space company providing satellites, satellite components, and in-space transportation services to government and commercial customers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Astrana Health names two executives to expand leadership team
- Splash Beverage settles $2.8M loan for $301K with Decathlon Alpha
- Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share